238 related articles for article (PubMed ID: 31990679)
21. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.
Uy GL; Duncavage EJ; Chang GS; Jacoby MA; Miller CA; Shao J; Heath S; Elliott K; Reineck T; Fulton RS; Fronick CC; O'Laughlin M; Ganel L; Abboud CN; Cashen AF; DiPersio JF; Wilson RK; Link DC; Welch JS; Ley TJ; Graubert TA; Westervelt P; Walter MJ
Leukemia; 2017 Apr; 31(4):872-881. PubMed ID: 27740633
[TBL] [Abstract][Full Text] [Related]
22. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of leukemic transformation in congenital neutropenia.
Link DC
Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
[TBL] [Abstract][Full Text] [Related]
24. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
25. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
26. AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.
Yan B; Claxton D; Huang S; Qiu Y
Exp Hematol; 2020 Jul; 87():13-19. PubMed ID: 32569759
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature.
Vélez-Ruelas MA; Martínez-Jaramillo G; Arana-Trejo RM; Mayani H
Hematology; 2006 Oct; 11(5):331-4. PubMed ID: 17607582
[TBL] [Abstract][Full Text] [Related]
28. Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.
Chang L; Cui Z; Shi D; Chu Y; Wang B; Wan Y; Ma Q; Zhang R; Li H; Cheng X; Cheng T; Zhu X; Li C; Yuan W
Exp Hematol Oncol; 2022 Sep; 11(1):64. PubMed ID: 36167633
[TBL] [Abstract][Full Text] [Related]
29. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
Stosch JM; Heumüller A; Niemöller C; Bleul S; Rothenberg-Thurley M; Riba J; Renz N; Szarc Vel Szic K; Pfeifer D; Follo M; Pahl HL; Zimmermann S; Duyster J; Wehrle J; Lübbert M; Metzeler KH; Claus R; Becker H
Br J Haematol; 2018 Sep; 182(6):830-842. PubMed ID: 29974943
[TBL] [Abstract][Full Text] [Related]
30. Clonal evolution and hierarchy in myeloid malignancies.
Takahashi K; Tanaka T
Trends Cancer; 2023 Sep; 9(9):707-715. PubMed ID: 37302922
[TBL] [Abstract][Full Text] [Related]
31. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Wong TN; Miller CA; Klco JM; Petti A; Demeter R; Helton NM; Li T; Fulton RS; Heath SE; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Welch JS; Graubert TA; Wilson RK; Ley TJ; Link DC
Blood; 2016 Feb; 127(7):893-7. PubMed ID: 26631115
[TBL] [Abstract][Full Text] [Related]
32. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
33. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
[TBL] [Abstract][Full Text] [Related]
34. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.
Dror Y; Freedman MH
Blood; 2001 May; 97(10):3011-6. PubMed ID: 11342425
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
Saygin C; Hu E; Zhang P; Sher S; Lozanski A; Doong TJ; Nicolet D; Orwick S; Labanowska J; Skinner JN; Cempre C; Kauffman T; Goettl VM; Heerema NA; Abruzzo L; Miller C; Lapalombella R; Behbehani G; Mims AS; Larkin K; Grieselhuber N; Walker A; Bhatnagar B; Bloomfield CD; Byrd JC; Lozanski G; Blachly JS
Leukemia; 2021 Dec; 35(12):3406-3420. PubMed ID: 34021247
[TBL] [Abstract][Full Text] [Related]
36. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.
Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C
Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164
[TBL] [Abstract][Full Text] [Related]
37. Clonal analysis of progenitor cells by interphase cytogenetics in patients with acute myeloid leukemia and myelodysplasia.
Van Der Lely N; Poddighe P; Wessels J; Hopman A; Geurts van Kessel A; De Witte T
Leukemia; 1995 Jul; 9(7):1167-72. PubMed ID: 7630192
[TBL] [Abstract][Full Text] [Related]
38. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
39. Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells.
Bezzerri V; Bardelli D; Morini J; Vella A; Cesaro S; Sorio C; Biondi A; Danesino C; Farruggia P; Assael BM; D'amico G; Cipolli M
Am J Hematol; 2018 Aug; 93(4):527-536. PubMed ID: 29285795
[TBL] [Abstract][Full Text] [Related]
40. Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.
Oppezzo A; Bourseguin J; Renaud E; Pawlikowska P; Rosselli F
J Clin Invest; 2020 Mar; 130(3):1377-1391. PubMed ID: 31877112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
